Severe chronic plaque psoriasis paediatric - ustekinumab - continuing authority application form (PB319)

Use this form to apply to continue PBS-subsidised treatment with ustekinumab for patients under 18 years with severe chronic plaque psoriasis.

Page last updated: 1 May 2024.
QC 55531